Renaissance Technologies’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Renaissance Technologies’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-41,600	Closed	-$1.51M	–	3579
2016 Q4	$1.51M	Sell	41,600 -51,000	-55%	-$1.8M	﹤0.01%	2355
2016 Q3	$3.53M	Buy	+92,600	New	+$1.37M	0.01%	1832

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Renaissance Technologies's CLCD Position: Q1 2017 in Review

Renaissance Technologies sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 41,600 shares — an estimated $1.51M sold.

Renaissance Technologies first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $3.53M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Renaissance Technologies reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Renaissance Technologies sold 41,600 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $1.51M.
Renaissance Technologies first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
Renaissance Technologies's CoLucid Pharmaceuticals, Inc. position peaked at $3.53M in Q3 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.